Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gram-negative bacterial surface antigens are a diverse array of molecules located on the outer membrane of Gram-negative bacteria, primarily consisting of lipopolysaccharides (LPS), outer membrane proteins (OMPs), and porins (Source: NCBI Bookshelf). These antigens are fundamental to bacterial survival, serving as a protective barrier against environmental stressors and facilitating the transport of essential nutrients (Source: Nature Reviews Microbiology). LPS, a hallmark of Gram-negative bacteria, acts as a potent endotoxin that can trigger systemic inflammatory response syndrome (SIRS) and septic shock by activating host immune pathways such as Toll-like receptor 4 (Source: PubMed). Due to their surface exposure, these molecules are primary targets for the development of antibacterial vaccines and monoclonal antibodies aimed at neutralizing toxins or promoting bacterial opsonization (Source: Frontiers in Immunology). Additionally, certain classes of antibiotics, such as polymyxins, exert their bactericidal effects by directly binding to and disrupting the LPS layer of the outer membrane (Source: Journal of Clinical Investigation).
Binding and neutralization of endotoxins (LPS), disruption of outer membrane integrity, and opsonization to facilitate phagocytic clearance by the host immune system.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-negative bacterial surface antigens.